Correlation Between R S and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both R S and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining R S and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between R S Software and Krebs Biochemicals and, you can compare the effects of market volatilities on R S and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in R S with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of R S and Krebs Biochemicals.

Diversification Opportunities for R S and Krebs Biochemicals

0.81

Correlation Coefficient

R S  Krebs Biochemicals

Very poor diversification

The 3 months correlation between RSSOFTWARE and Krebs is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding R S Software and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and R S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on R S Software are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of R S i.e., R S and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between R S and Krebs Biochemicals

Assuming the 90 days trading horizon R S Software is expected to under-perform the Krebs Biochemicals. But the stock apears to be less risky and, when comparing its historical volatility, R S Software is 1.06 times less risky than Krebs Biochemicals. The stock trades about -0.48 of its potential returns per unit of risk. The Krebs Biochemicals and is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  9,167  in Krebs Biochemicals and on December 29, 2024 and sell it today you would lose (2,530) from holding Krebs Biochemicals and or give up 27.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

R S Software  vs.  Krebs Biochemicals and

R S Software

Risk-Adjusted Performance

Very Weak

Over the last 90 days R S Software has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Krebs Biochemicals and

Risk-Adjusted Performance

Very Weak

Over the last 90 days Krebs Biochemicals and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with R S and Krebs Biochemicals

The main advantage of trading using opposite R S and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if R S position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind R S Software and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.